Skip to content

TEVA · Teva Pharmaceutical Industries Ltd

Healthcare · +0.9% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 8 feeds behind: FDA drug approvals, 1 day, and 7 more · Every feed →

On this page

The market view

Price chart

The interactive TEVA chart (by TradingView) loads here.

Our take

4 rules fired on TEVA

In short: none of these rules has solid or some evidence yet, so they show no clear lean on TEVA.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 4 rules
The 0–100 score for TEVA, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on TEVA, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of TEVA. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Congress purchases

Sparse history

Only 1 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual.

Latest 28 days
0
Earlier median
0
Earlier range
0–1
Distinct filers per 28 daysScale: 0–1
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 0

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Nov 23, 2016. Newest disclosure across this feed: Oct 15, 2026.

Earlier periods in the comparison: 12. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20260Partial; excluded
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 2; range: 0–4.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20262Partial; excluded
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20264Within stored history
Aug 24, 2026–Sep 20, 20262Within stored history
Sep 21, 2026–Oct 18, 2026Latest period2Within stored history
Congress purchases · Sparse history

Only 1 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–1.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20260Within stored history
Jun 29, 2026–Jul 26, 20261Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress sales · Sparse history

Only 0 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–0.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20260Within stored history
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Public officials

FDA & trials

FDA & trials · Oct 2026

  1. Record date
    FDA approval: Nda219007 ↗

    NDA · new application

  2. Record date
    FDA approval: Claravis ↗

    ANDA · supplement

  3. Record date
    FDA approval: Claravis ↗

    ANDA · supplement

  4. Record date
  5. Record date
All 24 records in this snapshot
  1. Record date
    FDA approval: Nda219007 ↗

    NDA · new application

  2. Record date
    FDA approval: Claravis ↗

    ANDA · supplement

  3. Record date
    FDA approval: Claravis ↗

    ANDA · supplement

  4. Record date
  5. Record date
  6. Disclosed
    Brian Savage · Sale

    Transaction dated Sep 18, 2026

  7. Disclosed
    Brian Savage · Sale

    Transaction dated Sep 18, 2026

  8. Disclosed
    Brian Savage · Sale

    Transaction dated Sep 18, 2026

  9. Disclosed
    Roberto Mignone · Sale

    Transaction dated Sep 18, 2026

  10. Filed
  11. Filed
  12. Record date
  13. Record date
  14. Disclosed
    Amir Weiss · Sale

    Transaction dated Aug 21, 2026

  15. Disclosed
    Amir Weiss · Sale

    Transaction dated Aug 21, 2026

  16. Disclosed
    Ronit Satchi-Fainaro · Sale

    Transaction dated Aug 21, 2026

  17. Disclosed
    Evan Lippman · Sale

    Transaction dated Aug 17, 2026

  18. Disclosed
    Tal Zvi Zaks · Sale

    Transaction dated Aug 5, 2026

  19. Disclosed
    Eric A Hughes · Sale

    Transaction dated Aug 3, 2026

  20. Disclosed
    Placid Jover · Sale

    Transaction dated Aug 3, 2026

  21. Record date
  22. Disclosed
    Alan Armstrong · Purchase

    Transaction dated Mar 30, 2026

  23. Disclosed
    Matthew Shields · Sale

    Transaction dated Jun 18, 2026

  24. Disclosed
    Eliyahu Sharon Kalif · Sale

    Transaction dated Jun 11, 2026

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

1 member bought, none sold · 1 Rep

  1. ▲ BUYAlan Armstrong Rep · Senate · OKTEVA Teva Pharmaceutical Industries Ltd$1K–$15Kdisclosed Jul 21 · filed 113 days after the trade · late 1 rule fired
See every Congress trade on TEVA →

Company insiders

0 buys · 8 sells (11 filed lots) · $17M sold

  1. ▼ SELLRoberto Mignone DirectorTEVA Teva Pharmaceutical Industries Ltd$14.4Mdisclosed Sep 22 · filed 4 days after the trade
  2. ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$98.8Kdisclosed Sep 22 · filed 4 days after the trade
  3. ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$12.2Kdisclosed Sep 22 · filed 4 days after the trade
  4. ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$174Kdisclosed Sep 22 · filed 4 days after the trade
  5. ▼ SELLRonit Satchi-Fainaro DirectorTEVA Teva Pharmaceutical Industries Ltd$15.5Kdisclosed Aug 25 · filed 4 days after the trade
  6. ▼ SELLAmir Weiss Chief Accounting OfficerTEVA Teva Pharmaceutical Industries Ltd$94.1Kdisclosed Aug 25 · filed 4 days after the trade
  7. ▼ SELLAmir Weiss Chief Accounting OfficerTEVA Teva Pharmaceutical Industries Ltd$261Kdisclosed Aug 25 · filed 4 days after the trade
  8. ▼ SELLEvan Lippman EVP, Business DevelopmentTEVA Teva Pharmaceutical Industries Ltd$680Kdisclosed Aug 19 · filed 2 days after the trade
  9. ▼ SELLTal Zvi Zaks DirectorTEVA Teva Pharmaceutical Industries Ltd$593disclosed Aug 10 · filed 5 days after the trade · late
  10. ▼ SELLEric A Hughes See "Remarks"TEVA Teva Pharmaceutical Industries Ltd$892Kdisclosed Aug 5 · filed 2 days after the trade
See every insider trade on TEVA →

Filings & events

Filing red flags 107

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 541

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Planned insider sales (Form 144) 2

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

2 in the last 90 days · 2 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

Biggest named funds (13F)

The largest TEVA holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on TEVA

  1. ▼ SELLRoberto Mignone DirectorTEVA Teva Pharmaceutical Industries Ltd$14.4Mdisclosed Sep 22 · filed 4 days after the trade
  2. ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$98.8Kdisclosed Sep 22 · filed 4 days after the trade
  3. ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$12.2Kdisclosed Sep 22 · filed 4 days after the trade
  4. ▼ SELLBrian Savage Interim Chief Legal OfficerTEVA Teva Pharmaceutical Industries Ltd$174Kdisclosed Sep 22 · filed 4 days after the trade
  5. ▼ SELLRonit Satchi-Fainaro DirectorTEVA Teva Pharmaceutical Industries Ltd$15.5Kdisclosed Aug 25 · filed 4 days after the trade
  6. ▼ SELLAmir Weiss Chief Accounting OfficerTEVA Teva Pharmaceutical Industries Ltd$94.1Kdisclosed Aug 25 · filed 4 days after the trade
  7. ▼ SELLAmir Weiss Chief Accounting OfficerTEVA Teva Pharmaceutical Industries Ltd$261Kdisclosed Aug 25 · filed 4 days after the trade
  8. ▼ SELLEvan Lippman EVP, Business DevelopmentTEVA Teva Pharmaceutical Industries Ltd$680Kdisclosed Aug 19 · filed 2 days after the trade
  9. ▼ SELLTal Zvi Zaks DirectorTEVA Teva Pharmaceutical Industries Ltd$593disclosed Aug 10 · filed 5 days after the trade · late
  10. ▼ SELLEric A Hughes See "Remarks"TEVA Teva Pharmaceutical Industries Ltd$892Kdisclosed Aug 5 · filed 2 days after the trade
  11. ▼ SELLPlacid Jover See "Remarks"TEVA Teva Pharmaceutical Industries Ltd$447Kdisclosed Aug 5 · filed 2 days after the trade
  12. ▲ BUYAlan Armstrong Rep · Senate · OKTEVA Teva Pharmaceutical Industries Ltd$1K–$15Kdisclosed Jul 21 · filed 113 days after the trade · late 1 rule fired
  13. ▼ SELLMatthew Shields EVP, Global OperationsTEVA Teva Pharmaceutical Industries Ltd$322Kdisclosed Jun 22 · filed 4 days after the trade
  14. ▼ SELLEliyahu Sharon Kalif EVP, Chief Financial OfficerTEVA Teva Pharmaceutical Industries Ltd$3.6Mdisclosed Jun 16 · filed 5 days after the trade · late
  15. ▼ SELLPatty Murray Dem · Senate · WATEVA Teva Pharmaceutical Industries Ltd$1K–$15Kdisclosed Jul 20, 2017 · filed 35 days after the trade
  16. ▼ SELLAngus S. King Jr Ind · Senate · METEVA Teva Pharmaceutical Industries Ltd$1K–$15Kdisclosed Nov 23, 2016 · filed 35 days after the trade
See the trades on TEVA in the feed →
People & votes

Which members of Congress traded TEVA, sponsored bills that touch it and voted on them — opens here.